PROVISION OF MEDICAL AID TO THE PATIENTS WITH PROLIFERATIVE VITREORETINOPATHY IN THE KAZAKHSTAN REPUBLIC
Background. Rhegmatogeneous retinal detachment accompanied with proliferative vitreoretinopathy is the commonest type of retinal detachment. This study aimed to elucidate the set of ocular and systemic co-morbidities and to assess the efficiency of surgical management.
Materials and methods: this cross-sectional study took place in Kazakh Research-Scientific Institute of Eye Diseases. The medical records of 362 patients operated within the past 10 years were undergone to retrospective analysis. Statistical analysis was carried through SPSS package (Version 20.0.).
Resuts: the hospitalization rate increased over the past 5 years (273 patients - 75/4%). Myopia was the commonest ocular co-morbidity (144-39.8%), following by pseudophakia (98-27.1%) and peripheral retinal degeneration (96-26.5%). Posterior vitrectomy was the commonest surgical intervention in the present category of patients (324-89,5%)? which witnesses for the disease severity.
Conclusion. The system of surgical aid for the patients with rhegmatogeneous retinal detachment, complicated by proliferative vitreoretinopathy could be generally considered as satisfactory, requiring certain improvements. The primary care eye practitioners need to follow the patients having risk factors of proliferative vitreoretinopathy development.
Almagul O. Baiyrkhanova 1, http://orcid.org/0000-0003-4033-5027
Tursunkul K. Botabekova 2.,
Yuliya M. Semenova 1,
Yevgeniy A. Yenin 3, http://orcid.org/0000-9450-0599
Anselm Kampik 4, http://orcid.org/0000-0001-6801-7114
Makpal S. Asainova 2, http://orcid.org/0000-0003-4888-6632
1 Semey State Medical University, Semey, Kazakhstan;
2 JSC "Kazakh Awards "Badge of honor" research institute of eye diseases", Almaty, Kazakhstan;
3 JSC National scientific center of surgery of A.N. Syzganov, Almaty, Kazakhstan;
4 Department of Ophthalmology, Ludwig-Maximilians-University, Munich, Germany
1. Baiyrkhanova A., Ismailova A., Botabekova T., Enin E., Semenova Y. Crosslinked Chitosan/PVA film, suturated with 5-Fluorouracil for the prevention of proliferative vitreoretinopathy // International Journal of Drug Delivery Technology. 2016 April-June; 6(2).
2. Blanchet K., Gilbert C., de Savigny D. Rethnking eye health systems to achieve universal coverage: the role of research. Blanchet K, Gilbert C, de Savigny D. // Br J Ophthalmol. 2014. Oct;98(10):1325-8.
3. Chandra A., Banerjee P., Davis D., Charteris D. Ethnic variation in rhegmatogeneous retinal detachments // Eye (Lond). 2015. Jun;29(6):803-7.
4. Foster A. Cataract and “Vision 2020-the right to sight” initiative // Br J Ophthalmol. 20 01 Jun;85(6):635-7.
5. He M., Mathenge W., Lewallen S., Courtright P. Global efforts to generate evidence for Vision 2020 // Ophthalmic Epidemiol. 2015;22(4):237-8.
6. Kaczmarek R., Misiuk-Hojło M. Patomechanisms in proliferative vitreoretinopathy // Klin Oczna. 2011;113(1-3):64-7.
7. Khan M.A., Brady C.J., Kaiser R.S. Clinical management of proliferative vitreoretinopathy: an update // Retina. 2015 Feb;35(2):165-75.
8. Lai F.H., Lo E.C., Chan V.C., Brelen M., Lo W.L., Young A.L. Combined pars plana vitrectomy-scleral buckle versus pars plana vitrectomy for proliferative vitreoretinopathy // Int Ophthalmol. 2016 Apr;36(2):217-24.
9. Lansingh С.V, A Eckert K. VISION 2020: Th Right to Sight in 7 Years? Med Hypothesis Discov Innov Ophthalmol. 2013 Summer;2(2):26-9.
10. Pararajasegaram R. VISION 2020 – the right to sight: from strategies to action // Am J Ophthalmol. 1999 Sep;128(3):359-60.
11. Pastor J.C., de la Rúa E.R., Martín F. Poliferative vitreoretinopathy: risk factors and pathobiology // Prog Retin Eye Res. 2002 Jan;21(1):127-44.
12. Paula J.S., Furtado J.M., Souza J.P., Lansingh V.C. Vision 2020: on the home stretch // Arq Bras Oftalmol. 2014 Nov-Dec;77(6):5-6.
13. Richter-Mueksch S., Kiss C.G., Radner W., Binder S., Velikay-Parel M. Proliferative vitreoretinopathy – at what risk is the fellow eye? // Wien Klin Wochenschr. 2004 Jan 31;116(1-2):32-6.
14. Shah V., Hall N., Goldacre M.J. Retinal detachment in Enland: database studies of trends over time and geographic variation // Br J Ophthalmol. 2015 May;99(5):639-43.
15. Shi H., Guo T., Liu P.C., Wang Q.Y., Du Y.R., Liu Q.Y., He M.M., Liu J.L., Yu J. Steroids as an adjunct for reducing the incidence of proliferative vitreoretinopathy after rhegmatogeneous retinal detachment surgery: a systematic review and meta-analysis // Drug Des Devel Ther. 2015 Mar 6;9:1393-400.
16. Tseng W., Cortez R.T., Ramirez G., Stinnett S., Jaffe G.J. Prevalence and risk factors for proliferative vitreoretinopathy in eyes with rhegmatogeneous retinal detachment but no previous vitreretinal surgery // Am J Ophthalmol. 2004 Jun;137(6):1105-15.
17. Vingolo E.M., Nebbioso M., Domanico D., Valente S., Frati P. Post-operative hospitalization in retinal detachment correlation to recurrences // Ann Ist Super Sanita. 2013;49(4):336-9.
Number of Views: 316
Category of articles:
Original articles
Bibliography link
Байырханова А.О., Ботабекова Т.К., Семенова Ю.М., Енин Е.А., Кампик A., Асаинова М.С. Организация медицинской помощи больным с пролиферативной витреоретинопатией в Республике Казахстан / / Наука и Здравоохранение. 2016. №4. С. 66-73. Baiyrkhanova A.O., Botabekova T.K., Semenova Y.M., Yenin Ye.A., Kampik A., Asainova M.S. Provision of medical aid to the patients with proliferative vitreoretinopathy in the Kazakhstan Republic. Nauka i Zdravookhranenie [Science & Healthcare]. 2016, 4, pp. 66-73.. Байырханова А.О., Ботабекова Т.К., Семенова Ю.М., Енин Е.А., Кампик A., Асаинова М.С. Қазақстан Республикасындағы пролиферативті витреоретинопатиясы бар науқастарға медициналық көмекті уйымдастыру / / Ғылым және Денсаулық сақтау. 2016. №4. Б. 66-73.Related publications:
ANALYSIS OF CLINICAL AND DEMOGRAPHIC INDICATORS OF PATIENTS WITH PARKINSON'S DISEASE IN THE SOUTHERN REGION OF KAZAKHSTAN
A COMPARATIVE STUDY OF DRUG POLICY REGARDING ORPHAN DISEASES IN THE USA, THE EUROPEAN UNION, AND THE REPUBLIC OF KAZAKHSTAN
MUTATIONS IN CARDIAC ION CHANNEL GENES IN KAZAKHSTANI PATIENTS WITH LONG QT SYNDROME
GENETIC FEATURES OF CONGENITAL DYSFUNCTION OF THE ADRENAL CORTEX CAUSED BY 21-HYDROXYLASE DEFICIENCY IN PERSONS OF KAZAKH NATIONALITY
NON-MOTOR SYMPTOMS IN PARKINSON'S DISEASE USING THE EXAMPLE OF AKTOBE PATIENTS